Metrics | 2020 | 2022 | 2023 |
---|---|---|---|
Revenue & Cost | |||
Total Revenue | $5.72B | $24.18B | $28.01B |
Cost of Revenue | $0.00 | $0.00 | - |
Gross Profit | $5.72B | $24.18B | $28.01B |
Gross Margin % | 100.00% | 100.00% | 100.00% |
Operating Expenses | |||
R&D Expenses | $0.00 | - | - |
SG&A Expenses | $0.00 | $9.61B | $11.14B |
Other Operating Expenses | $0.00 | $-23.29B | $16.87B |
Total Operating Expenses | $0.00 | $-13.68B | $28.01B |
Operating Performance | |||
Operating Income | $0.00 | $10.51B | $7.85B |
Operating Margin % | 0.00% | 43.44% | 28.01% |
EBITDA | $351.00M | $10.72B | $7.86B |
EBITDA Margin % | 6.14% | 44.33% | 28.04% |
Other Income/Expenses | |||
Interest Expense | $-3.36B | $3.22B | $12.61B |
Other Income/Expenses Net | $0.00 | $-3.20B | $-981.00M |
Income Before Tax | $0.00 | $7.30B | $6.87B |
Income Tax Expense | $0.00 | $1.46B | $1.41B |
Net Performance | |||
Net Income | $0.00 | $5.83B | $5.43B |
Net Margin % | 0.00% | 24.09% | 19.38% |
EPS | $0.00 | $3.69 | $3.27 |
Diluted EPS | $0.00 | $3.69 | $3.27 |
Metrics | 2020 | 2022 | 2023 |
---|---|---|---|
Assets | |||
Current Assets | |||
Cash & Cash Equivalents | $62.58B | $53.54B | $61.19B |
Short Term Investments | - | $72.91B | $69.44B |
Net Receivables | - | $10.08B | $8.34B |
Inventory | - | $-54.27B | - |
Other Current Assets | - | $54.27B | - |
Total Current Assets | $62.58B | $136.53B | $61.14B |
Non-Current Assets | |||
Property, Plant & Equipment (Net) | - | $3.86B | $3.62B |
Long Term Investments | - | $161.65B | $153.41B |
Tax Assets | - | - | - |
Other Non-Current Assets | - | $-185.04B | $426.74B |
Total Non-Current Assets | $-9.67B | $185.04B | $602.35B |
Total Assets | |||
Total Assets | $52.91B | $674.81B | $663.49B |
Liabilities | |||
Current Liabilities | |||
Accounts Payable | - | - | - |
Short Term Debt | $11.77B | $31.22B | $11.46B |
Tax Payables | - | - | - |
Deferred Revenue | - | - | - |
Other Current Liabilities | - | $-31.22B | $-11.46B |
Total Current Liabilities | $11.77B | $31.22B | - |
Non-Current Liabilities | |||
Long Term Debt | $41.30B | $39.83B | $51.48B |
Other Non-Current Liabilities | $9.01B | $-8.61B | - |
Total Non-Current Liabilities | $41.30B | $31.22B | $51.48B |
Total Liabilities | |||
Total Liabilities | $500.18B | $623.57B | $607.72B |
Shareholders Equity | |||
Equity Components | |||
Common Stock | $21.00M | $21.00M | $21.00M |
Retained Earnings | $64.19B | $71.90B | $74.03B |
Accumulated Other Comprehensive Income/Loss | $322.00M | $-11.41B | $-10.10B |
Total Shareholders Equity | $53.10B | $50.77B | $55.31B |
Key Metrics | |||
Balance Check | |||
Total Liabilities & Equity | $553.28B | $674.81B | $663.49B |
Total Debt | $53.06B | $71.05B | $62.94B |
Net Debt | $-9.52B | $17.50B | $1.74B |
Metrics | 2020 | 2022 | 2023 |
---|---|---|---|
Operating Activities | |||
Core Operations | |||
Net Income | - | $5.83B | $5.43B |
Depreciation & Amortization | $351.00M | $560.00M | $1.02B |
Stock Based Compensation | - | $202.00M | $224.00M |
Working Capital Changes | |||
Change in Accounts Receivable | - | - | - |
Change in Inventory | - | - | - |
Change in Accounts Payable | - | - | - |
Other Working Capital Changes | $50.81B | - | $-151.00M |
Total Working Capital Change | $3.37B | $6.79B | $-151.00M |
Other Operating | |||
Other Non-Cash Items | - | $14.73B | $2.15B |
Net Cash from Operations | $3.72B | $21.12B | $8.45B |
Investing Activities | |||
Capital Investments | |||
Capital Expenditures | - | - | $6.03B |
Purchase of Investments | $-68.66B | $-31.68B | $-9.27B |
Sale of Investments | $40.64B | $57.08B | $23.69B |
Other Investing Activities | $12.58B | $-30.15B | $-1.18B |
Net Cash from Investing | $-15.44B | $7.50B | $18.93B |
Financing Activities | |||
Debt & Equity | |||
Debt Repayment | $-14.48B | $-6.93B | $-4.08B |
Stock Repurchases | $-1.67B | $-1.17B | $-62.00M |
Dividends Paid | $-300.00M | $-3.08B | $-3.31B |
Other Financing Activities | $68.33B | $7.17B | $-13.22B |
Net Cash from Financing | $51.90B | $-3.98B | $-19.72B |
Cash Position | |||
Summary | |||
Net Change in Cash | $40.18B | $24.64B | $7.65B |
Cash at Beginning of Period | $22.41B | $28.91B | $53.54B |
Cash at End of Period | $62.58B | $53.54B | $61.19B |
Key Metrics | |||
Operating Cash Flow | $3.72B | $21.12B | $8.45B |
Capital Expenditure | - | - | $6.03B |
Free Cash Flow | $3.72B | $21.12B | $14.47B |